Journal of Addiction Research & Therapy
Open Access
Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Recommended Conferences
Google scholar citation report
Citations : 2384
Journal of Addiction Research & Therapy received 2384 citations as per google scholar report
Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- SafetyLit
- China National Knowledge Infrastructure (CNKI)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
Useful Links
Recommended Journals
Related Subjects
Share This Page
Journal of Addiction Research & Therapy : Citations & Metrics Report
Articles published in Journal of Addiction Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Addiction Research & Therapy has got h-index 23, which means every article in Journal of Addiction Research & Therapy has got 23 average citations.
Following are the list of articles that have cited the articles published in Journal of Addiction Research & Therapy.
| 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|
Year wise published articles |
0 | 0 | 9 | 59 | 48 |
Year wise citations received |
377 | 318 | 331 | 277 | 262 |
| Journal total citations count | 2384 |
| Journal impact factor | 12.60 |
| Journal 5 years impact factor | 9.26 |
| Journal cite score | 10.77 |
| Journal h-index | 23 |
| Journal h-index since 2016 | 20 |
| Journal Impact Factor 2020 formula |
| IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year |
| Journal 5-year Impact Factor 2020 formula |
| Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)} |
| Journal citescore |
| Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3 |
 |
Johnson PS, Johnson MW (2014) Investigation of “bath salts” use patterns within an online sample of users in the United States. Journal of psychoactive drugs 46: 369-378. |
| View at Publisher | View at Google Scholar | |
|
Schindler CW, Thorndike EB, Goldberg SR, Lehner KR, Cozzi NV, et al. (2016) Reinforcing and neurochemical effects of the “bath salts” constituents 3, 4-methylenedioxypyrovalerone (MDPV) and 3, 4-methylenedioxy-N-methylcathinone (methylone) in male rats. Psychopharmacology 233: 1981-1990. |
| View at Publisher | View at Google Scholar | |
|
Watterson LR, Olive MF (2014) Synthetic cathinones and their rewarding and reinforcing effects in rodents. Advances in Neuroscience. |
| View at Publisher | View at Google Scholar | |
|
Karlsson L, Andersson M, Kronstrand R, Kugelberg FC (2014) Mephedrone, methylone and 3, 4âmethylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice. Basic & clinical pharmacology & toxicology 115: 411-416. |
| View at Publisher | View at Google Scholar | |
|
Gregg RA, Rawls SM (2014) Behavioral pharmacology of designer cathinones: a review of the preclinical literature. Life sciences 97: 27-30. |
| View at Publisher | View at Google Scholar | |
|
Aarde SM, Creehan KM, Vandewater SA, Dickerson TJ, Taffe MA (2015) In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3, 4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats. Psychopharmacology 232: 3045-3055. |
| View at Publisher | View at Google Scholar | |
|
Baumann MH, Solis E, Watterson LR, Marusich JA, Fantegrossi WE, et al. (2014) Baths salts, spice, and related designer drugs: the science behind the headlines. Journal of neuroscience 34: 15150-15158. |
| View at Publisher | View at Google Scholar | |
|
Marusich JA, Antonazzo KR, Wiley JL, Blough BE, Partilla JS, Baumann MH (2014) Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3, 4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 87: 206-213. |
| View at Publisher | View at Google Scholar | |
|
Valente MJ, De Pinho PG, de Lourdes Bastos M, Carvalho F, Carvalho M (2014) Khat and synthetic cathinones: a review. Archives of toxicology 88: 15-45. |
| View at Publisher | View at Google Scholar | |
|
O'Neill N (2014) Mephedrone and multiplicity: User accounts of effects and harms. Contemporary Drug Problems 41: 417-443. |
| View at Publisher | View at Google Scholar | |
|
|
| View at Publisher | View at Google Scholar | |
|
Ben Mosbah H. " I was like a rose, now I look like a thorn" An exploratory study of women injecting drug users (WIDU) in Tunisia. |
| View at Publisher | View at Google Scholar | |
|
Beijer U, Scheffel Birath C, DeMartinis V, af Klinteberg B (2015) Facets of male violence against women with substance abuse problems: women with a residence and homeless women. Journal of interpersonal violence: 0886260515618211. |
| View at Publisher | View at Google Scholar | |
|
Dufort M, Stenbacka M, Gumpert CH (2015) Physical domestic violence exposure is highly associated with suicidal attempts in both women and men. Results from the national public health survey in Sweden. The European Journal of Public Health 25: 413-418. |
| View at Publisher | View at Google Scholar | |
|
Blum K, Febo M, Fried L, Li M, Dushaj K, et al. (2017) Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With “Dopamine Homeostasis” in Reward Deficiency Syndrome (RDS). Substance Use & Misuse 52: 535-547. |
| View at Publisher | View at Google Scholar | |
|
Blum K, Gold M, Clark HW, Dushaj K, Badgaiyan RD (2016) Should the United States Government Repeal Restrictions on Buprenorphine/Naloxone Treatment?. Substance use & misuse 51: 1674-1679. |
| View at Publisher | View at Google Scholar | |
|
Blum K, Oscar-Berman M, Blum SH, Madigan MA, Waite RL, et al. (2014) Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases?. Journal of alcoholism and drug dependence: 2. |
| View at Publisher | View at Google Scholar | |
|
Elian AA, Hackett J (2015) Urine analysis of buprenorphine/norbuprenorphine/naloxone in drugs and driving cases. J Appl Bioanal 1: 80-88. |
| View at Publisher | View at Google Scholar | |
|
Blum K, Han D, Giordano J, Lohmann R, Braverman ER, et al. (2013) Neurogenetics and Nutrigenomics of Reward Deficiency Syndrome (RDS): Stratification of Addiction Risk and Mesolimbic Nutrigenomic Manipulation of Hypodopaminergic Function. InOmics for Personalized Medicine: 365-398. |
| View at Publisher | View at Google Scholar | |
|
Badgaiyan RD, Sinha S, Blum K (2015) Do We Really Need to Continue Pharmacotherapy for Opioid Use Disorder (OUD) Indefinitely?. Journal of reward deficiency syndrome 1. |
| View at Publisher | View at Google Scholar | |
+32 25889658